PROJECT

Background

Biomacromolecules that are theoretically untargetable by small molecules and macromolecules are named “undruggable” (meaning that they cannot be discovered by conventional drug discovery platform technologies).
Taking proteins as an example, it was proposed that 75~85% of all proteins are undruggable proteins. Typical examples of andragalable biomacromolecules are various causative molecules of cancer, but they are also found in the cause of many other diseases.

Overview of Intermediate Molecular Drug Discovery

List of Major Research Projects

Drug Discovery Platform Technology Business

Drug discovery platform technology based on protein secondary structure

β-strand bridge peptides

more

Drug Discovery Platform Technology Business

Drug discovery platform technology based on nucleic acid skeleton

Information will be disclosed after the patent application is completed.

more

Drug Discovery Platform Technology Business

Screening method based on protein secondary structure and nucleic acid structure

more

Drug Discovery Business

Anticancer Drug Development Project

Information will be disclosed after the patent application is completed.

more

Drug Discovery Business

Project to Develop a Treatment for Amyotrophic Lateral Sclerosis

Information will be disclosed after the patent application is completed.

more